Trials / Sponsors / Neuraptive Therapeutics Inc.
Neuraptive Therapeutics Inc.
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People Wit Peripheral Nerve Injury Upper Limb, Peripheral Nerve Injury (PNI) | Phase 3 | 2025-02-10 |
| Terminated | A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair. Facial Paralysis | Phase 2 | 2022-07-12 |
| Completed | Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries Peripheral Nerve Injuries | Phase 2 | 2020-09-25 |
| Available | NTX-001 to Repair Peripheral Nerve Transection(s) Peripheral Nerve Transections, Acute or Planned in Upper Extremity and Facial Nerves | — | — |